SZSE:301281 (China)
Â
Class A
Â¥
31.13
(+2.44%)
Dec 25
Business Description
Shandong Keyuan Pharmaceutical Co Ltd
ISIN : CNE1000061V8
Share Class Description:
SZSE:301281: Class ACompare
Compare
Traded in other countries / regions
301281.China IPO Date
2023-04-04Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | 38.85 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 16.69 | |||||
| Beneish M-Score | -0.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EBITDA Growth Rate | -5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -9 | |||||
| 3-Year Book Growth Rate | 43 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.35 | |||||
| 9-Day RSI | 23.39 | |||||
| 14-Day RSI | 32.05 | |||||
| 6-1 Month Momentum % | 59.12 | |||||
| 12-1 Month Momentum % | 8.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.49 | |||||
| Quick Ratio | 5.45 | |||||
| Cash Ratio | 4.58 | |||||
| Days Inventory | 139.98 | |||||
| Days Sales Outstanding | 45.55 | |||||
| Days Payable | 72.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.95 | |||||
| Dividend Payout Ratio | 0.58 | |||||
| Forward Dividend Yield % | 0.95 | |||||
| 5-Year Yield-on-Cost % | 0.99 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.19 | |||||
| Operating Margin % | 9.26 | |||||
| Net Margin % | 11.46 | |||||
| FCF Margin % | -47.24 | |||||
| ROE % | 3.76 | |||||
| ROA % | 3.41 | |||||
| ROIC % | 4.69 | |||||
| ROC (Joel Greenblatt) % | 7.73 | |||||
| ROCE % | 2.98 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 66.5 | |||||
| PE Ratio without NRI | 58.78 | |||||
| Price-to-Owner-Earnings | 25.73 | |||||
| PEG Ratio | 4.05 | |||||
| PS Ratio | 7.51 | |||||
| PB Ratio | 2.46 | |||||
| Price-to-Tangible-Book | 2.64 | |||||
| Price-to-Operating-Cash-Flow | 77.92 | |||||
| EV-to-EBIT | 86.04 | |||||
| EV-to-EBITDA | 86.04 | |||||
| EV-to-Revenue | 7.96 | |||||
| EV-to-FCF | -16.86 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.36 | |||||
| Price-to-Graham-Number | 2.69 | |||||
| Price-to-Net-Current-Asset-Value | 6.54 | |||||
| Price-to-Net-Cash | 10.34 | |||||
| Earnings Yield (Greenblatt) % | 1.16 | |||||
| FCF Yield % | -6.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Keyuan Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 437.784 | ||
| EPS (TTM) (Â¥) | 0.457 | ||
| Beta | 0 | ||
| Volatility % | 112.09 | ||
| 14-Day RSI | 32.05 | ||
| 14-Day ATR (Â¥) | 1.44348 | ||
| 20-Day SMA (Â¥) | 34.1265 | ||
| 12-1 Month Momentum % | 8.51 | ||
| 52-Week Range (Â¥) | 18.52 - 58.66 | ||
| Shares Outstanding (Mil) | 108.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Keyuan Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Keyuan Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Keyuan Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281)'s stock price today?
The current price of SZSE:301281 is ¥31.13. The 52 week high of SZSE:301281 is ¥58.66 and 52 week low is ¥18.52.
When is next earnings date of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281)?
The next earnings date of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is .
Does Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is 0.95% (As of Today), Highest Dividend Payout Ratio of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) was 0.63. The lowest was 0.58. And the median was 0.63. The  Forward Dividend Yield % of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is 0.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers